• 1
    Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392:869.
  • 2
    Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med 1999; 5:124955.
  • 3
    Medzhitov R, Janway CA Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173:8997.
  • 4
    Dhodapkar MV, Steinman RM, Krasovsky J et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001; 193:2338.
  • 5
    Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194:76979.
  • 6
    Probst HC, Lagnel J, Kollias G, Van Den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 2003; 18:71320.
  • 7
    Bancherean J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:24552.
  • 8
    Stoll S, Delon J, Brotz TM, Germain RN. Dynamic imaging of T cell–dendritic cell interactions in lymph nodes. Science 2002; 296:18736.
  • 9
    Kitajima T, Caceres-Dittmar G, Tapia FJ et al. T cell-mediated terminal maturation of dendritic cells: loss of adhesive and phagocytotic capacities. J Immunol 1996; 157:23407.
  • 10
    Josien R, Li HL, Ingulli E et al. TRANCE, a tumour necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med 2000; 191:495502.
  • 11
    Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and non-polarized T cells. Nat Immunol 2000; 1:3116.
  • 12
    Nakamura I, Kajino K, Bamba H et al. Phenotypic stability of mature dendritic cells tuned by TLR or CD40 to control efficiency to cytotoxic T cell priming. Microbiol Immunol 2004; 48:2119.
  • 13
    Morel AS, Quaratino S, Douek DC, Londei M. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol 1997; 27:2634.
  • 14
    Corinti S, Albanesi C, La Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001; 166:43128.
  • 15
    Redpath S, Angulo A, Gascoigne NRJ, Ghazal P. Murine cytomegalovirus infection downregulates MHC class II expression on macrophages by induction of IL-10. J Immunol 1999; 162:67017.
  • 16
    Commeren DL, Van Soest PL, Karimi K et al. Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells. Immunology 2003; 110:18896.
  • 17
    MacDonald KPA, Pettit AR, Quinn C, Thomas GJ, Thomas R. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol 1999; 163:5599607.
  • 18
    Thurner B, Roder C, Dieckmann D et al. Generation of large numbers of fully mature and stable dendritic cells from leukopheresis products for clinical application. J Immunol Meth 1999; 223:115.
  • 19
    Demangel C, Bertolino P, Britton WJ. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol 2002; 32:9941002.
  • 20
    Ruedl C, Kopf M, Bachmann MF. CD8+ T cells mediate CD40-independent maturation of dendritic cells in vivo. J Exp Med 1999; 189:187584.
  • 21
    Lu Z, Yuan L, Zhou X et al. CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes. J Exp Med 2000; 191:54150.
  • 22
    Schuurhuis DH, Laban S, Toes REM et al. Immature dendritic cells acquire CD8+ cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J Exp Med 2000; 192:14550.
  • 23
    Bennett SR, Carbone FR, Karamalis F et al. Help for cytotoxic-T cell responses is mediated by CD40 signalling. Nature 1998; 393:47880.
  • 24
    Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T helper and a T killer cell. Nature 1998; 393:4748.
  • 25
    Schoenberger SP, Toes RE, Van Der Voort EI, Offringa R, Melief CJ. T cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions. Nature 1998; 393:4803.
  • 26
    Caux C, Massacrier C, Vanbervliet B et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994; 180:126372.
  • 27
    Cella M, Scheidegger D, Palmer-Lehmann K et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T−T help via APC activation. J Exp Med 1996; 184:74752.
  • 28
    Koch F, Stanzl U, Jennewein P et al. High level of IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996; 184:7416.
  • 29
    Shinde S, Wu Y, Guo Y et al. CD40L is important for induction of, but not response to, costimulatory activity: ICAM-1 as the second costimulatory molecule upregulated by CD40L. J Immunol 1996; 157:27648.
  • 30
    Kelleher M, Beverley PCL. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential. J Immunol 2001; 167:624755.
  • 31
    Schulz O, Edwards AD, Schito M et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000; 13:45362.
  • 32
    Morelli AE, Zahorchak AF, Larregina AT et al. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 2001; 98:151223.
  • 33
    Vaidyanathan H, Gentry JD, Weatherman A, Schwartzbach SD, Petro TM. Differential response of the murine IL-12 p35 gene to lipopolysaccharide compared with interferon-gamma and CD40 ligation. Cytokine 2001; 16:19.
  • 34
    Wan Y, Lu L, Bramson JL et al. Dendritic cell-derived IL-12 is not required for the generation of cytotoxic, IFN-gamma-secreting, CD8 + CTL in vivo. J Immunol 2001; 167:502733.
  • 35
    Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693702.
  • 36
    Bettelli E, Das MP, Howard ED et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998; 161:3299306.
  • 37
    Toto P, Feliciani C, Amerio P et al. Immune modulation in pemphigus vulgaris: role of CD28 and IL-10. J Immunol 2000; 164:5229.
  • 38
    Gately MK, Renzetti LM, Magram J et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16:495521.
  • 39
    Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:26374.
  • 40
    Rennick DM, Fort MM, Davidson NJ. Studies with IL-10–/– mice: an overview. J Leukoc Biol 1997; 61:38996.
  • 41
    Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299:10336.
  • 42
    Janssen EM, Lemmens EE, Wolfe T et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003; 421:8526.
  • 43
    Kobayashi K, Hernandez LD, Galan JE et al. IRAK-M is a negative regulator of toll-like receptor signalling. Cell 2002; 110:191202.
  • 44
    Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300:3379.
  • 45
    Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003; 300:33942.
  • 46
    Ahonen CL, Doxsee CL, McGurran SM et al. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J Exp Med 2004; 199:77584.